Correlation Between Eyenovia and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eyenovia and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and DiaMedica Therapeutics, you can compare the effects of market volatilities on Eyenovia and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and DiaMedica Therapeutics.
Diversification Opportunities for Eyenovia and DiaMedica Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eyenovia and DiaMedica is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Eyenovia i.e., Eyenovia and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Eyenovia and DiaMedica Therapeutics
Given the investment horizon of 90 days Eyenovia is expected to under-perform the DiaMedica Therapeutics. In addition to that, Eyenovia is 2.15 times more volatile than DiaMedica Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest 283.00 in DiaMedica Therapeutics on September 4, 2024 and sell it today you would earn a total of 266.00 from holding DiaMedica Therapeutics or generate 93.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyenovia vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Eyenovia |
| DiaMedica Therapeutics |
Eyenovia and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyenovia and DiaMedica Therapeutics
The main advantage of trading using opposite Eyenovia and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Eyenovia vs. Crinetics Pharmaceuticals | Eyenovia vs. Enanta Pharmaceuticals | Eyenovia vs. Amicus Therapeutics | Eyenovia vs. Connect Biopharma Holdings |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |